New marburg vaccine passes first safety test in humans
⭐️ VACCINE ⭐️
Completed
This early-stage study tested a new vaccine (PHV01) against Marburg virus, a rare but deadly disease. 36 healthy adults received either the vaccine or a placebo to check for side effects and measure immune response. The goal was to find a safe dose and see if the vaccine triggers…
Phase: PHASE1 • Sponsor: Public Health Vaccines LLC • Aim: ⭐️ VACCINE ⭐️
Last updated May 25, 2026 08:55 UTC